Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 22Osteoporosis 4Obesity 2Bone Diseases 2Vitamin D Deficiency 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Pain 1Neoplasm Metastasis 1Myocardial Ischemia 1Lung Neoplasms 1Heart Diseases 1Coronary Disease 1Colonic Neoplasms 1Chemotherapy-Related Cognitive Impairment 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1Biomarker Change Linked to Breast Cancer 1

Interventions

Zoledronic Acid 2Vitamin D 2saracatinib 1odanacatib 1Progestins 1Hormone Replacement Therapy 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Diseases × Vitamin D × Breast × Clear all
NCT00904423 2017-02-14

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Stanford University

Phase 1/2 Terminated
8 enrolled 4 charts
Breast

Bone Diseases, Breast Neoplasms

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡